The company focuses on developing diagnostic products for infectious diseases, genetic testing, tissue typing, neurodegeneration, and oncology. Their products include screening and confirmation tests for HIV, HCV, HTLV, and syphilis, genotyping tests for hepatitis B virus (HBV) and human papillomavirus, drug-resistance tests for TB and HBV, detection tests for cystic fibrosis and genetic risks, tissue typing tests for determining HLA type, and tests for Alzheimer's disease. In addition, Innogenetics distributes diagnostics products for breast and colon cancer. They also engage in the development of therapeutic vaccines for infectious diseases such as hepatitis C, hepatitis B, and human papillomaviruses. The company has collaborative agreements with various pharmaceutical and diagnostic companies. They primarily sell their products in several countries around the world.